Track RNAC and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
RNAC - Cartesian Therapeutics Inc. (RNAC) has a earnings per share of -$0.95, down 46.2% over the past year.
Latest EPS (Actual)
-$0.95
Beat Rate
62.5%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Apr 2026 | -$0.70 | -$0.95 | Miss | -35.71% |
| Mar 2026 | -$0.79 | -$2.71 | Miss | -242.59% |
| Nov 2025 | -$0.84 | -$1.38 | Miss | -64.29% |
| Aug 2025 | -$0.76 | $0.50 | Beat | +165.79% |
| May 2025 | -$0.71 | -$0.65 | Beat | +8.45% |
| Mar 2025 | -$0.83 | -$0.59 | Beat | +28.12% |
| Nov 2024 | -$0.55 | -$0.42 | Beat | +23.64% |
| Aug 2024 | -$0.09 | $0.64 | Beat | +811.11% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.